Literature DB >> 8087173

Cerebral ischemia induces alterations in tau and ubiquitin proteins.

D Dewar1, D I Graham, G M Teasdale, J McCulloch.   

Abstract

Excessive stimulation of glutamate receptors and elevation of intracellular calcium levels initiate the neurodegenerative process resulting from cerebral ischemia. However, the subsequent cascade of molecular changes which are of pathogenic significance is less well understood. Breakdown of the cytoskeleton may be involved in the progression from compromise of neuronal viability to irreversible damage. Alteration of the microtubule-associated protein tau, as reflected by increased Alz-50 immunoreactivity, was induced by permanent focal cerebral ischemia in vivo but only in a proportion of neurones. Alz-50 immunoreactive neurones did not exhibit the characteristics of irreversible ischemic cell damage. Increased immunoreactivity to the stress response protein ubiquitin was also induced by ischemia in a proportion of neurones. Both proteins are components of neurofibrillary tangles in Alzheimer's disease. Alterations of the microtubule-associated protein tau may be a feature of the early stages of the ischemia-induced degeneration and the ubiquitin response may be an attempt by compromised neurones to deal with the presence of abnormal proteins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8087173     DOI: 10.1159/000106716

Source DB:  PubMed          Journal:  Dementia        ISSN: 1013-7424


  12 in total

1.  Ischemic preconditioning prevents protein aggregation after transient cerebral ischemia.

Authors:  C Liu; S Chen; F Kamme; B R Hu
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

Review 2.  Irreversible translation arrest in the reperfused brain.

Authors:  Donald J DeGracia; Bingren R Hu
Journal:  J Cereb Blood Flow Metab       Date:  2006-08-16       Impact factor: 6.200

Review 3.  Participation of Amyloid and Tau Protein in Neuronal Death and Neurodegeneration after Brain Ischemia.

Authors:  Ryszard Pluta; Marzena Ułamek-Kozioł; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  Int J Mol Sci       Date:  2020-06-28       Impact factor: 5.923

Review 4.  Proteomic and Genomic Changes in Tau Protein, Which Are Associated with Alzheimer's Disease after Ischemia-Reperfusion Brain Injury.

Authors:  Marzena Ułamek-Kozioł; Stanisław Jerzy Czuczwar; Sławomir Januszewski; Ryszard Pluta
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

Review 5.  Brain Ischemia as a Prelude to Alzheimer's Disease.

Authors:  Ryszard Pluta; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  Front Aging Neurosci       Date:  2021-02-18       Impact factor: 5.702

Review 6.  Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes.

Authors:  Ryszard Pluta; Mirosław Jabłoński; Marzena Ułamek-Kozioł; Janusz Kocki; Judyta Brzozowska; Sławomir Januszewski; Wanda Furmaga-Jabłońska; Anna Bogucka-Kocka; Ryszard Maciejewski; Stanisław J Czuczwar
Journal:  Mol Neurobiol       Date:  2013-03-22       Impact factor: 5.590

Review 7.  Tau Protein Dysfunction after Brain Ischemia.

Authors:  Ryszard Pluta; Marzena Ułamek-Kozioł; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 8.  Shared Genomic and Proteomic Contribution of Amyloid and Tau Protein Characteristic of Alzheimer's Disease to Brain Ischemia.

Authors:  Ryszard Pluta; Marzena Ułamek-Kozioł; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  Int J Mol Sci       Date:  2020-04-30       Impact factor: 6.208

Review 9.  Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia.

Authors:  Marzena Ułamek-Kozioł; Stanisław J Czuczwar; Sławomir Januszewski; Ryszard Pluta
Journal:  Int J Mol Sci       Date:  2020-01-14       Impact factor: 5.923

Review 10.  Cross-Talk between Amyloid, Tau Protein and Free Radicals in Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy.

Authors:  Ryszard Pluta; Jacek Kiś; Sławomir Januszewski; Mirosław Jabłoński; Stanisław J Czuczwar
Journal:  Antioxidants (Basel)       Date:  2022-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.